Industry news, page-513

Superb MA and Com...excellent posts. For me there just seems to be more if's and but's on the psych side of our company compared to the cannabinoids. But you know what. The psych side doesn't come into my calculations to be honest. I'm focussed on the cannabinoid side as our more definitive pathway to success. Psilocybin is more of an icing in my viewpoint/ an added extra layer of value. If it doesn't work out I think that is minor compared to the OSA. I just love that we are not a 1 trick pony. What other medical start up has this many possible pathways to success. Name me one? Really appreciate those posts keep it up. Just my thought processes for all to digest. Let's keep up these great discussions.